OSM and hematologic disorder: In respect to other hematological malignancies, OSM mRNA are reportedly high in Philadelphia-negative myeloproliferative neoplasm (Ph- MPN) cells with a constitutively active JAK2 tyrosine kinase mutations such as JAK2V617F (34), with increased OSM protein concentration in Ph- MPN patient bone marrow cells and blood plasma (34).